Transverse Medical Completes Series B2 Capital Raise to Support Growth

Transverse Medical Inc. Successfully Completes Series B2 Financing Round to Advance Stroke Prevention Technology A pioneering early-stage medical device company specializing in Cerebral Embolic Protection (CEP) for stroke prevention during Transcatheter Aortic Valve Replacement (TAVR) procedures, today announced the successful…

Read MoreTransverse Medical Completes Series B2 Capital Raise to Support Growth

Pfizer’s Sasanlimab Combo Shows Significant Event-Free Survival Benefit in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer

Pfizer’s Sasanlimab Combination Significantly Extends Event-Free Survival in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer Patients Pfizer Inc. (NYSE: PFE) today announced encouraging results from the pivotal Phase 3 CREST trial, evaluating the efficacy and safety of sasanlimab, an investigational anti-PD-1…

Read MorePfizer’s Sasanlimab Combo Shows Significant Event-Free Survival Benefit in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer

UroGen Pharma Reports Promising Phase 1 Dose-Escalation Study Results for UGN-301 in Non-Muscle Invasive Bladder Cancer

UroGen Pharma Announces Promising Early Results from Phase 1 Study Evaluating UGN-301 for Non-Muscle Invasive Bladder Cancer UroGen Pharma Ltd. (Nasdaq: URGN), a biotechnology company committed to developing and commercializing innovative therapies for urothelial and specialty cancers, today announced positive…

Read MoreUroGen Pharma Reports Promising Phase 1 Dose-Escalation Study Results for UGN-301 in Non-Muscle Invasive Bladder Cancer

Merck KGaA, Darmstadt, Germany, to Acquire SpringWorks Therapeutics to Drive Sustainable Growth in Healthcare Portfolio

Merck KGaA, Darmstadt, Germany, to Acquire SpringWorks Therapeutics in Strategic Move to Accelerate Healthcare Growth Merck KGaA, Darmstadt, Germany (DAX: MRK), a global leader in science and technology, today announced that it has entered into a definitive agreement to acquire…

Read MoreMerck KGaA, Darmstadt, Germany, to Acquire SpringWorks Therapeutics to Drive Sustainable Growth in Healthcare Portfolio

Metrion Biosciences Unveils Nav1.9 High-Throughput Screening Assay to Expand Pain Research and Enhance Screening Capabilities

Metrion Biosciences Launches High-Throughput NaV1.9 Screening Assay to Accelerate Non-Opioid Pain Therapeutics Research Metrion Biosciences (“Metrion”), a leading specialist preclinical contract research organisation (CRO) and globally recognised expert in ion channel research services, today announced the launch of its newly…

Read MoreMetrion Biosciences Unveils Nav1.9 High-Throughput Screening Assay to Expand Pain Research and Enhance Screening Capabilities

eClinicalWorks & Sunoh.ai: Deeper Patient Interactions in Behavioral Health

eClinicalWorks & Sunoh.ai: Deeper Patient Interactions in Behavioral Health Health Opportunities for the People of East Texas (HOPE), a leading Federally Qualified Health Center (FQHC), has successfully implemented Sunoh.ai, an innovative AI-powered medical scribe seamlessly integrated with the eClinicalWorks® cloud-based…

Read MoreeClinicalWorks & Sunoh.ai: Deeper Patient Interactions in Behavioral Health

Vizient Reviews Ortho Innovations and IV Fluid Conservation

Vizient Reviews Ortho Innovations and IV Fluid Conservation Vizient, Inc., the nation’s leading provider-driven healthcare performance improvement company, has released the latest edition of its Medical Device Tech Watch, spotlighting advancements in orthopedic technology, strategies for conserving intravenous (IV) fluids,…

Read MoreVizient Reviews Ortho Innovations and IV Fluid Conservation